• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by China Jo-Jo Drugstores Inc.

    5/31/24 4:30:03 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $CJJD alert in real time by email
    6-K 1 ea0207160-6k_chinajo.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
    SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2024

     

    Commission File Number: 001-40724

     

    CHINA JO-JO DRUGSTORES, INC.
    (Translation of registrant’s name into English)

     

    4th Floor, Building 5, Renxin Yaju, Gong Shu District

    Hangzhou City, Zhejiang Province, People’s Republic of China, 310014
    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

     

    Explanatory Note

     

    This current report on Form 6-K was filed in connection with the resignation of Ms. Pingfan Wu as a director of China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), effective May 31, 2024. Ms. Wu’s resignation was not due to any disagreement with the Company regarding its business, finance, accounting, or any other matters.

     

    Exhibit No.   Description of Exhibit
    99.1   Press Release dated May 31, 2024

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Date: May 31, 2024 CHINA JO-JO DRUGSTORES, INC.
         
      By: /s/ Lei Liu  
      Name:  Lei Liu
      Title:  Chief Executive Officer

     

     

    2

     

     

    Get the next $CJJD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CJJD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CJJD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth

    HANGZHOU, China, Feb. 3, 2025 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced it has entered into definitive agreements for a strategic restructuring initiative to transition into an asset-light, wholesale-focused company, streamlining operations and enhancing profitability. The restructuring involved two major transactions (the "Transactions"): Acquisition transaction: The acquisition of Allright (Hangzhou) Internet Technology Co. Ltd. ("Allright"), a fast-growing company engaged in

    2/3/25 8:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results

    HANGZHOU, China, July 30, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2024. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to present our financial performance for fiscal year 2024, which reflects our commitment to maintaining a resilient business model in a dynamic market. We achieved a significant 42.1% revenue growth in our wholesale business, a result of our dedicated efforts in target

    7/30/24 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering

    HANGZHOU, China, June 11, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1,980,000 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for an aggregate gross proceeds of approximately $3.37 million. The closing of the sale of the securities is expected to occur on or about June 26, 2024, subject to satisfaction of customary closing co

    6/11/24 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by China Jo-Jo Drugstores Inc.

    SCHEDULE 13D/A - Ridgetech Inc. (0001856084) (Subject)

    3/4/25 4:50:18 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 6-K filed by China Jo-Jo Drugstores Inc.

    6-K - Ridgetech Inc. (0001856084) (Filer)

    3/3/25 9:41:03 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 6-K filed by China Jo-Jo Drugstores Inc.

    6-K - China Jo-Jo Drugstores, Inc. (0001856084) (Filer)

    2/3/25 8:30:06 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    Financials

    Live finance-specific insights

    View All

    China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results

    HANGZHOU, China, July 30, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2024. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to present our financial performance for fiscal year 2024, which reflects our commitment to maintaining a resilient business model in a dynamic market. We achieved a significant 42.1% revenue growth in our wholesale business, a result of our dedicated efforts in target

    7/30/24 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Reports Fiscal Year 2022 Financial Results

    HANGZHOU, China, July 28, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2022. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased with our fiscal year 2022 financial results, which reflect our continued growth momentum that we have achieved overall improvement across all key financial metrics. Compared with fiscal year 2021, our total revenue and gross profit increased by 23.5% and 24.9%, respecti

    7/28/22 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Reports First Half of Fiscal Year 2022 Financial Results

    HANGZHOU, China, Jan. 21, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, today announced its financial results for the first half of fiscal year 2022 ended September 30, 2021. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to have delivered a solid performance during the first half of fiscal year 2022 as we navigate through a challenging operating environment affected by multiple COVID-19 surges. We achieved record revenue of $78.48 million, up 26.8% from the same

    1/21/22 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by China Jo-Jo Drugstores Inc.

    SC 13D/A - China Jo-Jo Drugstores, Inc. (0001856084) (Subject)

    11/14/24 4:15:11 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by China Jo-Jo Drugstores Inc.

    SC 13D/A - China Jo-Jo Drugstores, Inc. (0001856084) (Subject)

    9/3/24 8:50:20 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13D/A filed by China Jo-Jo Drugstores Inc. (Amendment)

    SC 13D/A - China Jo-Jo Drugstores, Inc. (0001856084) (Subject)

    4/16/24 4:30:11 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    Leadership Updates

    Live Leadership Updates

    View All

    China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth

    HANGZHOU, China, Feb. 3, 2025 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced it has entered into definitive agreements for a strategic restructuring initiative to transition into an asset-light, wholesale-focused company, streamlining operations and enhancing profitability. The restructuring involved two major transactions (the "Transactions"): Acquisition transaction: The acquisition of Allright (Hangzhou) Internet Technology Co. Ltd. ("Allright"), a fast-growing company engaged in

    2/3/25 8:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples